Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Víctor A Arrieta^#^{1

2}, Andrew X Chen^#³, J Robert Kane¹, Seong Jae Kang¹, Cynthia Kassab⁴, Crismita Dmello¹, Junfei Zhao^{3

5}, Kirsten B Burdett⁶, Pavan S Upadhyayula⁷, Catalina Lee-Chang¹, Joseph Shilati¹, Dinesh Jaishankar⁸, Li Chen¹, Andrew Gould¹, Daniel Zhang¹, Jinzhou Yuan⁵, Wenting Zhao⁵, Xiaoyang Ling⁴, Jared K Burks⁹, Brice Laffleur¹⁰, Christina Amidei¹, Jeffrey N Bruce⁷, Rimas V Lukas¹¹, Jonathan T Yamaguchi¹, David Cieremans¹², Gerson Rothschild¹³, Uttiya Basu¹³, Matthew McCord¹⁴, Daniel J Brat¹⁴, Hui Zhang⁶, Lee A D Cooper¹⁴, Bin Zhang¹⁵, Peter Sims⁵, Tim F Cloughesy¹⁶, Robert Prins¹⁶, Peter Canoll¹⁷, Roger Stupp^{1

11

18}, Amy B Heimberger¹, Craig Horbinski^{1

14}, Fabio M Iwamoto¹⁹, Raul Rabadan^{20

21}, Adam M Sonabend²²

Affiliations

¹ Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
² PECEM, Faculty of Medicine, National Autonomous University of Mexico, Mexico, Mexico.
³ Program for Mathematical Genomics, Department of Systems Biology, Columbia University, New York, NY, USA.
⁴ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Biomedical Informatics, Columbia University, New York, NY, USA.
⁶ Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁷ Department of Neurosurgery, Columbia University, New York, NY, USA.
⁸ Robert Lurie Comprehensive Cancer Center and Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁰ INSERM U1236, University of Rennes 1, Etablissement Français du Sang, Rennes, France.
¹¹ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹² Department of Neurology, Columbia University, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center, New York, NY, USA.
¹³ Department of Microbiology and Immunology, Columbia University, New York, NY, USA.
¹⁴ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁵ Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁶ Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
¹⁷ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
¹⁸ Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁹ Department of Neurology, Columbia University, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center, New York, NY, USA. fi2146@cumc.columbia.edu.
²⁰ Program for Mathematical Genomics, Department of Systems Biology, Columbia University, New York, NY, USA. rr2579@cumc.columbia.edu.
²¹ Department of Biomedical Informatics, Columbia University, New York, NY, USA. rr2579@cumc.columbia.edu.
²² Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. adam.sonabend@northwestern.edu.

^# Contributed equally.

PMID: 35149861
DOI: 10.1038/s43018-022-00343-8

Published Erratum

Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Víctor A Arrieta et al. Nat Cancer. 2022 Mar.

. 2022 Mar;3(3):373.

doi: 10.1038/s43018-022-00343-8.

Authors

Affiliations

¹ Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
² PECEM, Faculty of Medicine, National Autonomous University of Mexico, Mexico, Mexico.
³ Program for Mathematical Genomics, Department of Systems Biology, Columbia University, New York, NY, USA.
⁴ Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
⁵ Department of Biomedical Informatics, Columbia University, New York, NY, USA.
⁶ Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁷ Department of Neurosurgery, Columbia University, New York, NY, USA.
⁸ Robert Lurie Comprehensive Cancer Center and Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
⁹ Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
¹⁰ INSERM U1236, University of Rennes 1, Etablissement Français du Sang, Rennes, France.
¹¹ Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹² Department of Neurology, Columbia University, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center, New York, NY, USA.
¹³ Department of Microbiology and Immunology, Columbia University, New York, NY, USA.
¹⁴ Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁵ Division of Hematology/Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁶ Department of Medical and Molecular Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
¹⁷ Department of Pathology and Cell Biology, Columbia University, New York, NY, USA.
¹⁸ Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
¹⁹ Department of Neurology, Columbia University, Vagelos College of Physicians and Surgeons Columbia University Irving Medical Center, New York, NY, USA. fi2146@cumc.columbia.edu.
²⁰ Program for Mathematical Genomics, Department of Systems Biology, Columbia University, New York, NY, USA. rr2579@cumc.columbia.edu.
²¹ Department of Biomedical Informatics, Columbia University, New York, NY, USA. rr2579@cumc.columbia.edu.
²² Department of Neurosurgery, Lou and Jean Malnati Brain Tumor Institute, Robert H Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. adam.sonabend@northwestern.edu.

^# Contributed equally.

PMID: 35149861
DOI: 10.1038/s43018-022-00343-8

No abstract available

PubMed Disclaimer

Erratum for

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma.
Arrieta VA, Chen AX, Kane JR, Kang SJ, Kassab C, Dmello C, Zhao J, Burdett KB, Upadhyayula PS, Lee-Chang C, Shilati J, Jaishankar D, Chen L, Gould A, Zhang D, Yuan J, Zhao W, Ling X, Burks JK, Laffleur B, Amidei C, Bruce JN, Lukas RV, Yamaguchi JT, Cieremans D, Rothschild G, Basu U, McCord M, Brat DJ, Zhang H, Cooper LAD, Zhang B, Sims P, Cloughesy TF, Prins R, Canoll P, Stupp R, Heimberger AB, Horbinski C, Iwamoto FM, Rabadan R, Sonabend AM. Arrieta VA, et al. Nat Cancer. 2021 Dec;2(12):1372-1386. doi: 10.1038/s43018-021-00260-2. Epub 2021 Nov 29. Nat Cancer. 2021. PMID: 35121903 Free PMC article.

Publication types

Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Affiliations

Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Authors

Affiliations

Erratum for

Publication types

Grants and funding